Showing Results for
From:PLoS ONE (Vol. 5, Issue 7) Peer-ReviewedTo prevent progression to AIDS, persons infected with human immunodeficiency virus type 1 (HIV-1) must remain on highly active antiretroviral therapy (HAART) indefinitely since this modality does not eradicate the...
From:PLoS ONE (Vol. 11, Issue 5) Peer-ReviewedDespite tremendous progress in our understanding of human immunodeficiency virus (HIV) natural history and advances in HIV treatment, there is neither an approved vaccine nor a cure for infection. Here, we describe the...
From:PLoS ONE (Vol. 9, Issue 1) Peer-ReviewedAuthor(s): Debra A. Wadford 1, Robert C. Kauffman 1, Jesse D. Deere 1, Scott T. Aoki 1, Richard A. Stanton 2, Joanne Higgins 1, Koen K. A. Van Rompay 3, Andradi Villalobos 1, James H. Nettles 2, Raymond F. Schinazi 4,...
From:Proceedings of the National Academy of Sciences of the United States (Vol. 116, Issue 26) Peer-ReviewedAbstract Only
From:PLoS ONE (Vol. 9, Issue 2) Peer-ReviewedAuthor(s): Jesse D. Deere 1, Robert C. Kauffman 1, Elda Cannavo 1, Joanne Higgins 1, Andradi Villalobos 1, Lourdes Adamson 1, Raymond F. Schinazi 2, Paul A. Luciw 1,3, Thomas W. North 1,4,* Introduction Human...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it